Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: A preliminary report

Fitoterapia

Volumn 70, Issue 6, 1999, Pages 586-592

  Calapai, Gioacchino ^a   Firenzuoli, Fabio ^b   Saitta, Antonio ^a   Squadrito, Francesco ^a   R Arlotta, Maria ^a   Costantino, Giuseppina ^a   Inferrera, Giuseppina ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

Antiobesity effects; Cardiovascular toxicity; Citrus aurantium; Synephrine

Indexed keywords

OXEDRINE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CITRUS FRUIT; CONTROLLED STUDY; DRUG TOXICITY; FOOD INTAKE; MALE; MEDICINAL PLANT; MORTALITY; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; RAT; WEIGHT GAIN;

ANIMALIA; CITRUS AURANTIUM;

EID: 0032745904     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0367-326X(99)00093-3     Document Type: Article

References (10)

1. Hashimoto K., Yasuda T., Ohsawa K.J. J Chromatogr. 623:1992;386.
2. Kusu F., Li X.D., Takamura K. Chem Pharm Bull. 40:1992;3284.
3. Jordan R., Midgley J.M., Thonoor C.M., Williams C.M. J Pharm Pharmacol. 39:1987;752.
4. Williams C.M., Couch M.W., Thonoor C.M., Midgley J.M. J Pharm Pharmacol. 39:1987;153.
5. Calapai G., Caputi A.P. Regulatory Peptides. 66:1996;117.
6. Calapai G., Corica F., Allegra A. et al. Br J Pharmacol. 125:1998;798.
7. Kusu F., Matsumoto K., Takamura K. Chem Pharm Bull. 43:1995;1158.
8. Park J.H., Keeley L.L. Gen Comp Endocrinol. 110:1998;88.
9. Huang Y.T., Wang G.F., Chen C.F., Chen C.C., Hong C.Y., Yang M.C. Life Sci. 57:1995;2011.
10. Keogh A.M., Baron D.W. Br Med J. 291:1985;940.